A detailed history of Van Eck Associates Corp transactions in Davita Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 4,424 shares of DVA stock, worth $751,637. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,424
Previous 5,562 20.46%
Holding current value
$751,637
Previous $771,000 6.61%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$133.98 - $165.19 $152,469 - $187,986
-1,138 Reduced 20.46%
4,424 $720,000
Q2 2024

Jul 31, 2024

SELL
$126.11 - $147.14 $186,895 - $218,061
-1,482 Reduced 21.04%
5,562 $771,000
Q1 2024

Apr 30, 2024

SELL
$103.89 - $139.21 $994,850 - $1.33 Million
-9,576 Reduced 57.62%
7,044 $972,000
Q4 2023

Feb 05, 2024

SELL
$73.2 - $108.8 $775,627 - $1.15 Million
-10,596 Reduced 38.93%
16,620 $1.74 Million
Q3 2023

Nov 08, 2023

BUY
$94.53 - $112.68 $1.94 Million - $2.32 Million
20,563 Added 309.08%
27,216 $2.57 Million
Q2 2023

Aug 03, 2023

BUY
$81.58 - $100.93 $195,302 - $241,626
2,394 Added 56.21%
6,653 $669,000
Q1 2023

May 03, 2023

BUY
$74.68 - $85.82 $103,730 - $119,203
1,389 Added 48.4%
4,259 $345,000
Q4 2022

Feb 08, 2023

BUY
$65.42 - $99.31 $91,064 - $138,239
1,392 Added 94.18%
2,870 $214,000
Q3 2022

Oct 27, 2022

BUY
$80.24 - $95.27 $1,925 - $2,286
24 Added 1.65%
1,478 $122,000
Q2 2022

Aug 03, 2022

BUY
$76.05 - $123.38 $110,576 - $179,394
1,454 New
1,454 $116,000
Q1 2021

May 13, 2021

SELL
$99.98 - $123.89 $604,679 - $749,286
-6,048 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$82.82 - $117.4 $334,013 - $473,474
4,033 Added 200.15%
6,048 $710,000
Q3 2020

Nov 12, 2020

BUY
$79.57 - $91.84 $160,333 - $185,057
2,015 New
2,015 $173,000

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $15.5B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.